je.st
news
Tag: patients
Electric Spinal Stimulation Gives Hope to Paralyzed Patients
2013-11-04 17:17:00| Electrical Construction & Maintenance
In both animal and human experiments, researchers are using electricity to restore function to paralyzed lower limbs. read more
Tags: hope
electric
patients
stimulation
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer
2013-10-29 06:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Phase II/III Trial of MK-3475 in Patients with NSCLC Currently Enrolling WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Language: English Contact: MerckMedia Contacts:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-500-1101orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
The Merck Manual Go-To Home Guide for Symptoms Helps Patients Assess When to Worry and When to Wait, Determine Next Steps
2013-10-23 23:04:50| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the availability of a newly published book, The Merck Manual Go-To Home Guide for Symptoms, which offers essential information on when to seek medical attention and when it may suffice for consumers to address their ailments at home. Language: English Ticker Slug: Ticker: MRK Exchange: NYSE Multimedia read more
FDA: J&J hepatitis C drug cures 80% of patients
2013-10-22 17:22:36| Biotech - Topix.net
An experimental hepatitis C drug from Johnson & Johnson appears to be slightly more effective at eliminating the virus than currently available treatments, though federal safety reviewers say it also causes rash and sunburn in some patients.
FDA: J&J hepatitis C drug cures 80 pct of patients
2013-10-22 17:03:09| Food - Topix.net
An experimental hepatitis C drug from Johnson & Johnson appears to be slightly more effective at eliminating the virus than currently available treatments, though federal safety reviewers say it also causes rash and sunburn in some patients.
Sites : [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] next »